Use of snake venom prothrombin activators in blood collection tubes to produce high quality serum to improve patient outcomes

在采血管中使用蛇毒凝血酶原激活剂来生产高质量的血清，以改善患者的治疗效果

• 批准号: nhmrc : 1038834
• 负责人: Dr Goce Dimeski
• 金额: $ 18.98万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Development Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/use-snake-venom-patient-outcomes/111219
• 关键词: Use; snake; venom; prothrombin; activators

The timely availability of high quality serum and plasma samples are of the utmost importance for accurate biochemical analysis in a clinical setting. This requirement is particularly true for patients on anti-clotting therapeutic agents such as warfarin and heparin. In this study we will employ potent prothrombin activators purified from snake venom to enhance the clotting efficiency of blood for serum preparation for biochemical analysis.

及时获得高质量的血清和血浆样本对于临床环境中准确的生化分析至关重要。这一要求对于使用华法林和肝素等抗凝治疗药物的患者尤其适用。在这项研究中，我们将使用从蛇毒中纯化的强效凝血酶原激活剂来提高血液的凝血效率，用于生化分析的血清制备。